Related references
Note: Only part of the references are listed.
Article
Biochemistry & Molecular Biology
Masaya Yamazaki et al.
Summary: Tumor-initiating cells with high expression of receptor tyrosine kinase-like orphan receptor 1 (ROR1) have partial epithelial-mesenchymal transition (EMT)-like signature and act as the origin of heterogeneous tumor cells in PDAC. ROR1 depletion suppresses tumor growth, recurrence after chemotherapy, and metastasis by inducing the expression of Aurora kinase B (AURKB) through activating E2F via c-Myc. ROR1 is transcriptionally dependent on YAP/BRD4 binding at the enhancer region and targeting this pathway reduces ROR1 expression and prevents PDAC growth.
Review
Oncology
Abdel Nasser Hosein et al.
Summary: Pancreatic ductal adenocarcinoma (PDAC) is an aggressive cancer that is often diagnosed at advanced stages, leading to limited treatment options. Recent advancements in targeted therapy and immunotherapy for different subtypes of PDAC are reviewed in this article, with a focus on the current preclinical and clinical evidence supporting these approaches and the potential of combination treatments.
Review
Oncology
Ashton A. Connor et al.
Summary: Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest epithelial malignancies, with increasing research over several decades leading to a better understanding of its carcinogenesis and significant progress in genomics and transcriptomics. The inclusion of PDAC data in international pan-cancer analyses has provided further insights, and the study of PDAC evolution and heterogeneity has led to the proposal of an evolutionary model based on genomics studies of human PDAC.
NATURE REVIEWS CANCER
(2022)
Article
Oncology
Shivani Srivastava et al.
Summary: CAR-T therapy shows limited efficacy in lung adenocarcinoma, but combining oxaliplatin, cyclophosphamide, and anti-PD-L1 can improve CAR-T cell infiltration into tumors and enhance efficacy.
Article
Multidisciplinary Sciences
Ievgenia Pastushenko et al.
Summary: This study reveals that mutation of the FAT1 gene promotes tumor initiation, progression, invasiveness, stemness, and metastasis. Loss of function of FAT1 activates a CAMK2-CD44-SRC axis while inactivates EZH2, playing important roles in the expression of YAP1 and ZEB1.
Article
Oncology
Mengyu Tu et al.
Summary: Large-scale genomic profiling of pancreatic cancer has identified two distinct subtypes - 'classical' and 'basal-like' - within the stromal immune microenvironment, influencing differential prognosis. Basal-like neoplastic state is sustained through BRD4-mediated cJUN/AP1 expression, inducing CCL2 to recruit TNF-alpha-secreting macrophages, which in turn forces classical neoplastic cells into an aggressive state via lineage reprogramming. Integration of various data sources revealed JUNB/AP1 (classical) and cJUN/AP1 (basal-like) driven regulation of PDAC subtypes.
Article
Genetics & Heredity
Michelle Chan-Seng-Yue et al.
Review
Gastroenterology & Hepatology
Eric A. Collisson et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY
(2019)
Article
Cell & Tissue Engineering
Michael Y. Choi et al.
Article
Multidisciplinary Sciences
Gwen Lomberk et al.
NATURE COMMUNICATIONS
(2018)
